MIJ821
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MIJ821, covering 2021-05-19 to 2025-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD) [Phase 2]